Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobacco Cessation in HIV Care in Kenya
NCT05351606Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2023
- Primary completion
- Jan 2025
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion, nicotine patch in Tobacco Use Disorder (TUD), sponsored by University of California, San Francisco. Started May 2023; status: completed.
02
Drugs
bupropionnicotine patch
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05351606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351606.